一呼百应|多线治疗失败后,替雷利珠单抗为肺腺癌患者带来新的生机( 四 )


[4] Zhijie Wang, et al. CSCO 2018; Jun Zhao, et al. ASCO 2019; Zhijie Wang, et al. CSCO 2019
[5] ShunLu, et al. 2020 ESMO (RATIONALE 304).
【一呼百应|多线治疗失败后,替雷利珠单抗为肺腺癌患者带来新的生机】[6]ShunLu, et al. 2020 CSCO (RATIONALE 304).